Alternatives to Davinci Neuroscience

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.